Global PCOS Treatment Market By Treatment (Surgeries v/s Drug Treatment), By Diagnosis (Pelvic Examination, Ultrasound, Blood Tests), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Fertility Clinics), By Region, Forecast & Opportunities, 2

Global PCOS Treatment Market By Treatment (Surgeries v/s Drug Treatment), By Diagnosis (Pelvic Examination, Ultrasound, Blood Tests), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Fertility Clinics), By Region, Forecast & Opportunities, 2025

Global PCOS treatment market is expected to grow at a formidable rate during the forecast period. The global PCOS treatment market is driven by the increasing prevalence of diabetes and obesity among the woman population. Additionally, increasing cases of hormonal imbalances in the women are further expected to propel the market during forecast period. Furthermore, ongoing technological advancements and new product launches by the major players operating in the market for the development of new drugs and treatment options are anticipated to foster the growth of market through 2025.

The global PCOS treatment market is segmented based on treatment, diagnosis, end user, company and region. Based on treatment the market can be bifurcated into surgeries and drug treatment. The surgeries segment can further be categorized into ovarian wedge resection and laparoscopic ovarian drilling. The laparoscopic ovarian drilling segment is expected to dominate the market during forecast years. This can be attributed to the fertility problems faced by the women due to this problem and the response to medications generally weakens over time in women. Additionally, this procedure is cost effective and easy to perform which is driving the growth of segment across the globe.

Regionally, the global PCOS treatment market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these, North America is expected to witness significant growth during the forecast years in the global PCOS treatment market owing to the growing prevalence of overweight and obese women population in the region.



Major players operating in the global PCOS treatment market include Bristol-Myers Squibb Company, Bayer AG, Pfizer, Inc., Abbott Laboratories, Merck & Co., Inc., Sanofi SA, AstraZeneca Plc, Novartis AG, Teva Pharmaceutical Industries Limited, Ferring Pharmaceuticals, Inc., Neurocrine Biosciences, Inc., EffRx Pharmaceuticals SA, Mylan N.V., Millendo Therapeutics, Inc. and others. The companies are developing advanced technologies and launching new services in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

Historical Years: 2015-2018
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2021–2025

Objective of the Study:

To analyze and estimate the market size of global PCOS treatment market from 2015 to 2018.
To estimate and forecast the market size of global PCOS treatment market from 2019 to 2025 and growth rate until 2025.
To classify and forecast global PCOS treatment market based on treatment, diagnosis, end user, company and regional distribution.
To identify dominant region or segment in the global PCOS treatment market.
To identify drivers and challenges for global PCOS treatment market.
To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global PCOS treatment market.
To identify and analyze the profile of leading players operating in global PCOS treatment market.
To identify key sustainable strategies adopted by market players in global PCOS treatment market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals & clinics, ambulatory surgical centers, fertility clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals & clinics, ambulatory surgical centers, fertility clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals & clinics, ambulatory surgical centers, fertility clinics and presence of all major players across the globe.

TechSci Research calculated the market size of global PCOS treatment market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

PCOS treatment hospitals & clinics, ambulatory surgical centers, fertility centers and other stakeholders
Government bodies such as regulating authorities and policy makers
Organizations, forums and alliances related to PCOS treatment
Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals & clinics, ambulatory surgery centers, fertility clinics, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global PCOS treatment market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Global PCOS Treatment Market, By Treatment:
Surgeries
Ovarian Wedge Resection
Laparoscopic Ovarian Drilling
Drug Treatment
Oral Contraceptives
Antiandrogens
Anti-Depressants
Anti-Obesity Drugs
Others
Global PCOS Treatment Market, By Diagnosis:
Pelvic Examination
Ultrasound
Blood Tests
Global PCOS Treatment Market, By End User:
Hospitals & Clinics
Ambulatory Surgical Centers
Fertility Clinics
Global PCOS Treatment Market, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Asia-Pacific
China
Japan
India
South Korea
Australia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
South America
Brazil
Argentina
Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global PCOS treatment market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global PCOS Treatment Market
4. Executive Summary
5. Voice of Customer
5.1. Brand Awareness (Aided/Unaided)
5.2. Product Awareness
5.3. Customer Satisfaction Analysis
5.4. Unmet Needs/Challenges
6. Global PCOS Treatment Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Treatment (Surgeries v/s Drug Treatment)
6.2.1.1. By Surgeries (Ovarian Wedge Resection, Laparoscopic Ovarian Drilling)
6.2.1.2. By Drug Treatment (Oral Contraceptives, Antiandrogens, Anti-Depressants, Insulin-Sensitizing Agents, Anti-Obesity Drugs, Others)
6.2.2. By Diagnosis (Pelvic Examination, Ultrasound, Blood Tests)
6.2.3. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Fertility Clinics)
6.2.4. By Company (2019)
6.2.5. By Region
6.3. Product Market Map
7. Asia-Pacific PCOS Treatment Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Treatment
7.2.2. By Diagnosis
7.2.3. By End User
7.2.4. By Country
7.3. Asia-Pacific: Country Analysis
7.3.1. China PCOS Treatment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Treatment
7.3.1.2.2. By Diagnosis
7.3.1.2.3. By End User
7.3.2. India PCOS Treatment Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Treatment
7.3.2.2.2. By Diagnosis
7.3.2.2.3. By End User
7.3.3. Australia PCOS Treatment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Treatment
7.3.3.2.2. By Diagnosis
7.3.3.2.3. By End User
7.3.4. Japan PCOS Treatment Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Treatment
7.3.4.2.2. By Diagnosis
7.3.4.2.3. By End User
7.3.5. South Korea PCOS Treatment Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Treatment
7.3.5.2.2. By Diagnosis
7.3.5.2.3. By End User
8. Europe PCOS Treatment Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Treatment
8.2.2. By Diagnosis
8.2.3. By End User
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. France PCOS Treatment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Treatment
8.3.1.2.2. By Diagnosis
8.3.1.2.3. By End User
8.3.2. Germany PCOS Treatment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Treatment
8.3.2.2.2. By Diagnosis
8.3.2.2.3. By End User
8.3.3. United Kingdom PCOS Treatment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Treatment
8.3.3.2.2. By Diagnosis
8.3.3.2.3. By End User
8.3.4. Italy PCOS Treatment Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Treatment
8.3.4.2.2. By Diagnosis
8.3.4.2.3. By End User
8.3.5. Spain PCOS Treatment Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Treatment
8.3.5.2.2. By Diagnosis
8.3.5.2.3. By End User
9. North America PCOS Treatment Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Treatment
9.2.2. By Diagnosis
9.2.3. By End User
9.2.4. By Country
9.3. North America: Country Analysis
9.3.1. United States PCOS Treatment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Treatment
9.3.1.2.2. By Diagnosis
9.3.1.2.3. By End User
9.3.2. Mexico PCOS Treatment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Treatment
9.3.2.2.2. By Diagnosis
9.3.2.2.3. By End User
9.3.3. Canada PCOS Treatment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Treatment
9.3.3.2.2. By Diagnosis
9.3.3.2.3. By End User
10. South America PCOS Treatment Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Treatment
10.2.2. By Diagnosis
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil PCOS Treatment Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Treatment
10.3.1.2.2. By Diagnosis
10.3.1.2.3. By End User
10.3.2. Argentina PCOS Treatment Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Treatment
10.3.2.2.2. By Diagnosis
10.3.2.2.3. By End User
10.3.3. Colombia PCOS Treatment Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Treatment
10.3.3.2.2. By Diagnosis
10.3.3.2.3. By End User
11. Middle East and Africa PCOS Treatment Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Treatment
11.2.2. By Diagnosis
11.2.3. By End User
11.2.4. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa PCOS Treatment Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Treatment
11.3.1.2.2. By Diagnosis
11.3.1.2.3. By End User
11.3.2. Saudi Arabia PCOS Treatment Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Treatment
11.3.2.2.2. By Diagnosis
11.3.2.2.3. By End User
11.3.3. UAE PCOS Treatment Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Treatment
11.3.3.2.2. By Diagnosis
11.3.3.2.3. By End User
11.3.4. Kuwait PCOS Treatment Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Treatment
11.3.4.2.2. By Diagnosis
11.3.4.2.3. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Clinical Trials
15. Competitive Landscape
15.1. Bristol-Myers Squibb Company
15.2. Bayer AG
15.3. Pfizer, Inc.
15.4. Abbott Laboratories
15.5. Merck & Co., Inc.
15.6. Sanofi SA
15.7. AstraZeneca Plc
15.8. Novartis AG
15.9. Teva Pharmaceutical Industries Limited
15.10. Ferring Pharmaceuticals, Inc.
15.11. Neurocrine Biosciences, Inc.
15.12. EffRx Pharmaceuticals SA
15.13. Mylan N.V.
15.14. Millendo Therapeutics, Inc.
16. Strategic Recommendations
17. About Us & Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook